Hamed Shahbazi
CIK: 0001942711
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Shahbazi Hamed
Shahbazi Hamed (SEC CIK 0001942711) files insider reports with the SEC as Director of Niagen Bioscience, Inc. (NAGE) and Director of Metals Royalty Co Inc. (TMCR).
Signal8 holds 3 ownership filings by Shahbazi Hamed (1 Form 3, 2 Form 4), filed between Jul 3, 2025 and Jun 26, 2026. Those filings report 2 transactions, from Jun 24, 2025 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Shahbazi Hamed's filings is in LOS ANGELES, CA.
Recent filings by Shahbazi Hamed
Other insiders filing for Niagen Bioscience, Inc. (NAGE)
- Lopez Carlos Luis, SVP, General Counsel
- Pamir Ozan, Chief Financial Officer
- Fried Robert N, Chief Executive Officer
- YU Wing Tak Wendy, Director
- Ng Wang Yu Gary, Director
- Cohen Ann, Director